Agency Information Collection Activities: Submission for OMB Review; Comment Request, 58919-58920 [2021-23185]
Download as PDF
<![CDATA[
58919
Federal Register / Vol. 86, No. 203 / Monday, October 25, 2021 / Notices
Date: November 22, 2021.
Time: 10:00 a.m. to 4:00 p.m. Eastern Time
(ET).
Agenda: The meeting will cover committee
business items including updates on pain
workforce enhancement and pain research
concepts. It will include follow up of IPRCC
recommendations and member updates.
Webcast Live: https://videocast.nih.gov/.
Deadline: Submission of intent to submit
written/electronic statement for comments:
Monday, November 15th, by 5:00 p.m. ET.
Place: National Institutes of Health,
Building 31, 31 Center Drive Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Linda L. Porter, Ph.D.,
Director, Office of Pain Policy and Planning,
Office of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A31, Bethesda, MD
20892, Phone: (301) 451–4460, Email:
Linda.Porter@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The meeting will be open to the public via
NIH Videocast https://videocast.nih.gov/.
Visit the IPRCC website for more
information: https://iprcc.nih.gov. Agenda and
any additional information for the meeting
will be posted when available.
Dated: October 19, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Institutional Training Mechanism Study
Section.
Date: December 10, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Lindsay M. Garvin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–Y,
Bethesda, MD 20892, (301) 827–7911,
lindsay.garvin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 19, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–23192 Filed 10–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–23191 Filed 10–22–21; 8:45 am]
BILLING CODE 4140–01–P
Substance Abuse and Mental Health
Services Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
National Institutes of Health
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer at (240) 276–0361.
jspears on DSK121TN23PROD with NOTICES1
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
Project: Minority AIDS InitiativeManagement Reporting Tools (MAI–
MRTs)—(OMB No. 0930–0357)—
Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) is requesting from
the Office of Management and Budget
(OMB) approval for the revised Minority
AIDS Initiative (MAI) monitoring tools,
which includes both youth and adult
questionnaires as well as the quarterly
progress report. This renewal includes
the inclusion of new cohorts.
The cohorts of grantees funded by the
MAI and included in this clearance
request are:
• Capacity Building Initiative 2017
• Capacity Building Initiative 2018
• Prevention Navigators 2017
• Prevention Navigators 2019
• Prevention Navigators 2020
• Prevention Navigators 2021
The target population for the MAI
grantees will be at-risk minority
adolescents and young adults. All MAI
grantees are expected to report their
monitoring data using SAMHSA’s
Strategic Prevention Framework (SPF)
to target minority populations, as well
as other high-risk groups residing in
communities of color with high
prevalence of Substance Abuse and
HIV/AIDS. The primary objectives of the
monitoring tools include:
• Assess the success of the MAI in
reducing risk factors and increasing
protective factorsassociated with the
transmission of the Human
Immunodeficiency Virus (HIV),
Hepatitis C Virus (HCV), and other
sexually transmitted diseases (STD).
• Measure the effectiveness of
evidence-based programs and
infrastructure development activities
such as: Outreach and training,
mobilization of key stakeholders,
substance abuse and HIV/AIDS
counseling and education, testing,
referrals to appropriate medical
treatment and/or other intervention
strategies (i.e., cultural enrichment
activities, educational and vocational
resources, social marketing campaigns,
and computer-based curricula).
• Investigate intervention types and
features that yield the best outcomes for
specific population groups.
• Assess the extent to which access to
health care was enhanced for
population groups and individuals
vulnerable to behavioral health
disparities residing in communities
targeted by funded interventions.
• Assess the process of adopting and
implementing the SPF with the target
populations.
TABLE 1—ESTIMATES OF ANNUALIZED HOUR BURDEN
Number of
respondents
Type of respondent activity
Quarterly Progress Report .................................................
VerDate Sep<11>2014
18:00 Oct 22, 2021
Jkt 256001
PO 00000
Frm 00061
Responses per
respondent
197
Fmt 4703
Sfmt 4703
Total
responses
4
E:\FR\FM\25OCN1.SGM
732
25OCN1
Hours per
response
Total burden
hours
4
2,928
58920
Federal Register / Vol. 86, No. 203 / Monday, October 25, 2021 / Notices
TABLE 1—ESTIMATES OF ANNUALIZED HOUR BURDEN—Continued
Number of
respondents
Type of respondent activity
Total
responses
Hours per
response
Total burden
hours
Adult questionnaire ............................................................
Youth questionnaire ...........................................................
10,000
2,500
2
2
20,000
5,000
.20
.20
4,000
1000
Total ............................................................................
12,697
..........................
25,732
........................
7,928
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2021–23185 Filed 10–22–21; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2020–0016]
Meetings To Implement Pandemic
Response Voluntary Agreement Under
Section 708 of the Defense Production
Act
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Announcement of meetings.
AGENCY:
The Federal Emergency
Management Agency (FEMA) is holding
a series of meetings to implement the
Voluntary Agreement for the
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic.
DATES: The first meeting took place on
Tuesday, October 12, 2021, from 10:00
a.m. to 12 p.m. Eastern Time (ET). The
second meeting took place on Thursday,
October 14, 2021, from 10:30 a.m. to 11
a.m. ET. The third meeting took place
on Thursday, October 21, 2021, from
10:30 a.m. to 11 a.m. ET. The fourth
meeting will take place on Thursday,
October 28, 2021, from 10:30 a.m. to 11
a.m. ET. The fifth meeting will take
place on Thursday, November 4, 2021,
from 10:30 a.m. to 11 a.m. ET.
FOR FURTHER INFORMATION CONTACT:
Robert Glenn, Office of Business,
Industry, Infrastructure Integration, via
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
Responses per
respondent
VerDate Sep<11>2014
18:00 Oct 22, 2021
Jkt 256001
email at OB3I@fema.dhs.gov or via
phone at (202) 212–1666.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is provided as required
by section 708(h)(8) of the Defense
Production Act (DPA), 50 U.S.C.
4558(h)(8), and consistent with 44 CFR
part 332.
The DPA authorizes the making of
‘‘voluntary agreements and plans of
action’’ with representatives of industry,
business, and other interests to help
provide for the national defense.1 The
President’s authority to facilitate
voluntary agreements with respect to
responding to the spread of COVID–19
within the United States was delegated
to the Secretary of Homeland Security
in Executive Order 13911.2 The
Secretary of Homeland Security further
delegated this authority to the FEMA
Administrator.3
On August 17, 2020, after the
appropriate consultations with the
Attorney General and the Chairman of
the Federal Trade Commission, FEMA
completed and published in the Federal
Register a ‘‘Voluntary Agreement,
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic’’ (Voluntary
Agreement).4 Unless terminated earlier,
the Voluntary Agreement is effective
until August 17, 2025, and may be
extended subject to additional approval
by the Attorney General after
consultation with the Chairman of the
Federal Trade Commission. The
Agreement may be used to prepare for
or respond to any pandemic, including
COVID–19, during that time.
On December 7, 2020, the first plan of
action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
1 50
U.S.C. 4558(c)(1).
FR 18403 (Apr. 1, 2020).
3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020);
DHS Delegation Number 09052 Rev. 00 (Jan. 3,
2017).
4 85 FR 50035 (Aug. 17, 2020). The Attorney
General, in consultation with the Chairman of the
Federal Trade Commission, made the required
finding that the purpose of the voluntary agreement
may not reasonably be achieved through an
agreement having less anticompetitive effects or
without any voluntary agreement and published the
finding in the Federal Register on the same day. 85
FR 50049 (Aug. 17, 2020).
2 85
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Manufacture, Allocation, and
Distribution of Personal Protective
Equipment (PPE) to Respond to COVID–
19 (PPE Plan of Action)—was finalized.5
The PPE Plan of Action established
several sub-committees under the
Voluntary Agreement, focusing on
different aspects of the PPE Plan of
Action.
On May 24, 2021, four additional
plans of action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Diagnostic Test Kits and
other Testing Components to respond to
COVID–19, the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Drug Products, Drug
Substances, and Associated Medical
Devices to respond to COVID–19, the
Plan of Action to Establish a National
Strategy for the Manufacture,
Allocation, and Distribution of Medical
Devices to respond to COVID–19, and
the Plan of Action to Establish a
National Strategy for the Manufacture,
Allocation, and Distribution of Medical
Gases to respond to COVID–19—were
finalized.6 These plans of action
established several sub-committees
under the Voluntary Agreement,
focusing on different aspects of each
plan of action.
The meetings were chaired by the
FEMA Administrator’s delegates from
the Office of Response and Recovery
(ORR) and Office of Policy and Program
Analysis (OPPA), attended by the
Attorney General’s delegates from the
U.S. Department of Justice, and attended
by the Chairman of the Federal Trade
Commission’s delegates. In
implementing the Voluntary Agreement,
FEMA adheres to all procedural
requirements of 50 U.S.C. 4558 and 44
CFR part 332.
Meeting Objectives: The objectives of
the meetings are as follows:
1. Meet the Sub-Committee for Oxygen
under the Medical Gases Plan of Action to
establish priorities related to the COVID–19
response under the Voluntary Agreement.
5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR
79020 (Dec. 8, 2020).
6 See 86 FR 27894 (May 24, 2021). See also 86 FR
28851 (May 28, 2021).
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 86, Number 203 (Monday, October 25, 2021)]
[Notices]
[Pages 58919-58920]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23185]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer at (240) 276-0361.
Project: Minority AIDS Initiative-Management Reporting Tools (MAI-
MRTs)--(OMB No. 0930-0357)--Revision
The Substance Abuse and Mental Health Services Administration
(SAMHSA), Center for Substance Abuse Prevention (CSAP) is requesting
from the Office of Management and Budget (OMB) approval for the revised
Minority AIDS Initiative (MAI) monitoring tools, which includes both
youth and adult questionnaires as well as the quarterly progress
report. This renewal includes the inclusion of new cohorts.
The cohorts of grantees funded by the MAI and included in this
clearance request are:
Capacity Building Initiative 2017
Capacity Building Initiative 2018
Prevention Navigators 2017
Prevention Navigators 2019
Prevention Navigators 2020
Prevention Navigators 2021
The target population for the MAI grantees will be at-risk minority
adolescents and young adults. All MAI grantees are expected to report
their monitoring data using SAMHSA's Strategic Prevention Framework
(SPF) to target minority populations, as well as other high-risk groups
residing in communities of color with high prevalence of Substance
Abuse and HIV/AIDS. The primary objectives of the monitoring tools
include:
Assess the success of the MAI in reducing risk factors and
increasing protective factorsassociated with the transmission of the
Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and other
sexually transmitted diseases (STD).
Measure the effectiveness of evidence-based programs and
infrastructure development activities such as: Outreach and training,
mobilization of key stakeholders, substance abuse and HIV/AIDS
counseling and education, testing, referrals to appropriate medical
treatment and/or other intervention strategies (i.e., cultural
enrichment activities, educational and vocational resources, social
marketing campaigns, and computer-based curricula).
Investigate intervention types and features that yield the
best outcomes for specific population groups.
Assess the extent to which access to health care was
enhanced for population groups and individuals vulnerable to behavioral
health disparities residing in communities targeted by funded
interventions.
Assess the process of adopting and implementing the SPF
with the target populations.
Table 1--Estimates of Annualized Hour Burden
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total burden
Type of respondent activity respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
Quarterly Progress Report...... 197 4 732 4 2,928
[[Page 58920]]
Adult questionnaire............ 10,000 2 20,000 .20 4,000
Youth questionnaire............ 2,500 2 5,000 .20 1000
--------------------------------------------------------------------------------
Total...................... 12,697 ............... 25,732 .............. 7,928
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2021-23185 Filed 10-22-21; 8:45 am]
BILLING CODE 4162-20-P
